120 related articles for article (PubMed ID: 14103596)
1. [CLINICAL EFFECTIVENESS OF VERINA (NYLIDRIN HYDROCHLORIDE)].
TAKAO H; KIMURA M; NORII T
Chiryo; 1963; 45():2268-70. PubMed ID: 14103596
[No Abstract] [Full Text] [Related]
2. [CONSIDERATIONS ON THE ACTIVITY OF A VASODILATOR: 1-(P-HYDROXYPHENYL)-2-(1-METHYL-2-PHENOXYETHYLAMINE)-PROPANOL-1-HYDROCHLORIDE (DUVADILAN)].
ANFOSSI F; GUARRAGGI A
Minerva Cardioangiol; 1964 Mar; 12():123-7. PubMed ID: 14142071
[No Abstract] [Full Text] [Related]
3. [INDIRECT FIBRINOLYTIC AND ANTICOAGULANT TREATMENT OF THROMBOSIS].
MENEGHINI P; AVANZI G
Policlinico Prat; 1964 May; 71():803-20. PubMed ID: 14159143
[No Abstract] [Full Text] [Related]
4. [Endarterial therapy of peripheral vascular diseases; new indications: antihistamines in Raynaud's and Burger's diseases; postpituitary extract in acrocyanosis].
PRATESI F
Riv Crit Clin Med; 1951; 51(1-2):99-194. PubMed ID: 14854679
[No Abstract] [Full Text] [Related]
5. [OUR THERAPEUTIC RESULTS WITH THE SYNCARDON MACHINE].
BUGAR MESZAROS K; KUSZTOS D
Orv Hetil; 1964 Dec; 105():2467-70. PubMed ID: 14231357
[No Abstract] [Full Text] [Related]
6. [Effects of nylidrin hydrochloride (verina) upon retinal blood vessels].
KIKUNI M; HAYATSU H
Rinsho Ganka; 1962 Jan; 16():75-80. PubMed ID: 14455897
[No Abstract] [Full Text] [Related]
7. NONATHEROSCLEROTIC OCCLUSIVE LESIONS OF SMALL ARTERIES.
HARDY JD; CONN JH; FAIN WR
Surgery; 1965 Jan; 57():1-13. PubMed ID: 14242046
[No Abstract] [Full Text] [Related]
8. [THE HEMATIC GLYCOPROTEINS IN PERIPHERAL ARTERY DISEASES].
TESAURO B
Rass Int Clin Ter; 1963 Aug; 43():859-65. PubMed ID: 14092249
[No Abstract] [Full Text] [Related]
9. [DIGITAL GANGRENE OF THE UPPER EXTREMITIES. 9 CASES].
LENG LEVY J; DAVID CHAUSSE J; LAGOARDE J; PICOT C; BROUSTET JP
J Med Bord; 1964 Dec; 141():1851-65. PubMed ID: 14257684
[No Abstract] [Full Text] [Related]
10. NYLIDRIN HYDROCHLORIDE IN SENILE ARTERIOSCLEROSIS.
TREPTOW KR; AFFLECK DC; ROEHL CA; SOELLING WM
Arch Neurol; 1963 Aug; 9():142-6. PubMed ID: 14054151
[No Abstract] [Full Text] [Related]
11. CURRENT STATUS OF SYMPATHECTOMY.
PALUMBO LT
Clin Med (Northfield); 1963 Nov; 70():2035-42. PubMed ID: 15446085
[No Abstract] [Full Text] [Related]
12. [RESEARCH ON GLUCOSE TOLERANCE IN NON-DIABETIC VASCULAR DISEASE PATIENTS].
VITELLI A; MARTINO P; GAVELLO F
G Gerontol; 1963 Aug; 11():621-39. PubMed ID: 14084732
[No Abstract] [Full Text] [Related]
13. VASCULAR DISEASES OF THE LIMBS.
CARTIER GE
Can Nurse; 1964 Mar; 60():224-32. PubMed ID: 14126081
[No Abstract] [Full Text] [Related]
14. [Effect of the vasodilator agent nylidrin (Verina) on cerebral circulation and its clinical results].
ATARASHI J; AKIRA S; KAWAMOTO M; TSUNEOKA K; IIZUKA A; KUBO F
Chiryo; 1962 Jan; 44():106-9. PubMed ID: 13863065
[No Abstract] [Full Text] [Related]
15. CYCLANDELATE (CYCLOSPASMOL) IN THE TREATMENT OF PERIPHERAL CIRCULATORY DISEASES.
SMITH AL
Angiology; 1965 Jan; 16():1-7. PubMed ID: 14258038
[No Abstract] [Full Text] [Related]
16. [ROLE OF ADRENAL HISTOLOGICAL CHANGES IN ARTERITIS OBLITERANS AND IN RAYNAUD'S DISEASE].
PIETA-POLOMSKI E; WALCZAK M; WOJCIECHOWSKI K
Pol Przegl Chir; 1963; 35():1024-6. PubMed ID: 14108206
[No Abstract] [Full Text] [Related]
17. [EFFECT OF VERINA (NYLIDRIN) ON THE ERG].
SANADA T; KUBO T
Rinsho Ganka; 1964 Jul; 18():861-4. PubMed ID: 14176389
[No Abstract] [Full Text] [Related]
18. [FUNCTIONAL ARTERIAL COMPLICATIONS WITH THE USE OF AMPHOTERICIN B].
RAPHAEL A; WOLOSKER M; CINELLI M; BUENONETO J; SAMPAIO SA
Rev Assoc Med Bras; 1963; 9():313-6. PubMed ID: 14126521
[No Abstract] [Full Text] [Related]
19. Thromboangiitis obliterans: a rare cause of a reversible Raynaud's phenomenon.
Noël B; Krayenbühl B; Cerottini JP; Guggisberg D; Buxtorf K; Pires A; Panizzon RG
Dermatology; 2000; 200(4):363-5. PubMed ID: 10894979
[TBL] [Abstract][Full Text] [Related]
20. [Results of radiotherapy in 16 cases of Raynaud's disease and in 10 cases of Buerger's disease].
ZANETTI E; DE PONTI C
Minerva Med; 1956 Jun; 47(49):1947-51. PubMed ID: 13348328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
